- Home
- IMMP vs FRST Comparison
IMMP vs FRST Comparison
Compare IMMP & FRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- FRST
- Stock Information
- Founded
- IMMP 1987
- FRST 2004
- Country
- IMMP Australia
- FRST United States
- Employees
- IMMP N/A
- FRST N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- FRST Major Banks
- Sector
- IMMP Health Care
- FRST Finance
- Exchange
- IMMP Nasdaq
- FRST Nasdaq
- Market Cap
- IMMP 211.1M
- FRST 220.5M
- IPO Year
- IMMP N/A
- FRST 2006
- Fundamental
- Price
- IMMP $1.89
- FRST $9.43
- Analyst Decision
- IMMP Buy
- FRST Buy
- Analyst Count
- IMMP 2
- FRST 1
- Target Price
- IMMP $8.50
- FRST $14.00
- AVG Volume (30 Days)
- IMMP 659.8K
- FRST 86.2K
- Earning Date
- IMMP 05-23-2025
- FRST 04-29-2025
- Dividend Yield
- IMMP N/A
- FRST 4.25%
- EPS Growth
- IMMP N/A
- FRST N/A
- EPS
- IMMP N/A
- FRST N/A
- Revenue
- IMMP $3,019,249.00
- FRST $100,555,000.00
- Revenue This Year
- IMMP $50.37
- FRST $21.74
- Revenue Next Year
- IMMP N/A
- FRST $50.03
- P/E Ratio
- IMMP N/A
- FRST N/A
- Revenue Growth
- IMMP 24.11
- FRST N/A
- 52 Week Low
- IMMP $1.32
- FRST $7.59
- 52 Week High
- IMMP $3.34
- FRST $13.52
- Technical
- Relative Strength Index (RSI)
- IMMP 54.39
- FRST 61.65
- Support Level
- IMMP $1.78
- FRST $8.66
- Resistance Level
- IMMP $2.71
- FRST $9.69
- Average True Range (ATR)
- IMMP 0.17
- FRST 0.36
- MACD
- IMMP 0.02
- FRST 0.15
- Stochastic Oscillator
- IMMP 25.45
- FRST 87.62
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About FRST Primis Financial Corp.
Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, It focuses on making loans secured mainly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in several industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts, and certificates of deposit.